Shanghai Bio-heart Delays Dispatch of Circular for Stake Sale in Unit

MT Newswires Live

01-13

Shanghai Bio-heart Biological Technology (HKG:2185) delayed the dispatch of a circular regarding the disposal of a 45.3% stake in Zhejiang Bioheart Medical Equipment to Jan. 27, a Friday Hong Kong bourse filing said.

The interventional cardiovascular device company needs additional time to finalize certain information to be included in the circular.

The firm is selling the stake to Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 155.6 million yuan capital injection in the unit, according to a Jan. 2 disclosure.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2503373639"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2503373639\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2503373639?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-13 17:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503373639","market":"sh","top_or_hot":-1,"title":"Shanghai Bio-heart Delays Dispatch of Circular for Stake Sale in Unit","media":"MT Newswires Live","content":"<html><body><p> Shanghai Bio-heart Biological Technology (HKG:2185) delayed the dispatch of a circular regarding the disposal of a 45.3% stake in Zhejiang Bioheart Medical Equipment to Jan. 27, a Friday Hong Kong bourse filing said.</p><p>The interventional cardiovascular device company needs additional time to finalize certain information to be included in the circular.</p><p>The firm is selling the stake to Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 155.6 million yuan capital injection in the unit, according to a Jan. 2 disclosure.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Bio-heart Delays Dispatch of Circular for Stake Sale in Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Bio-heart Delays Dispatch of Circular for Stake Sale in Unit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-13 17:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Shanghai Bio-heart Biological Technology (HKG:2185) delayed the dispatch of a circular regarding the disposal of a 45.3% stake in Zhejiang Bioheart Medical Equipment to Jan. 27, a Friday Hong Kong bourse filing said.</p><p>The interventional cardiovascular device company needs additional time to finalize certain information to be included in the circular.</p><p>The firm is selling the stake to Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 155.6 million yuan capital injection in the unit, according to a Jan. 2 disclosure.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02185","symbol_name":"百心安-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2503373639","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503373639","pubTimestamp":1736760273,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shanghai Bio-heart Biological Technology  delayed the dispatch of a circular regarding the disposal of a 45.3% stake in Zhejiang Bioheart Medical Equipment to Jan. 27, a Friday Hong Kong bourse filing said.The interventional cardiovascular device company needs additional time to finalize certain information to be included in the circular.The firm is selling the stake to Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 155.6 million yuan capital injection in the unit, according to a Jan. 2 disclosure.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02185":"百心安-B","BK1100":"医疗保健设备"},"translate_title":"上海生物心脏推迟发出出售单位股权的通函","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02185":0.9},"content_text":"Shanghai Bio-heart Biological Technology (HKG:2185) delayed the dispatch of a circular regarding the disposal of a 45.3% stake in Zhejiang Bioheart Medical Equipment to Jan. 27, a Friday Hong Kong bourse filing said.The interventional cardiovascular device company needs additional time to finalize certain information to be included in the circular.The firm is selling the stake to Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 155.6 million yuan capital injection in the unit, according to a Jan. 2 disclosure.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}